Fulgent Genetics (NASDAQ: FLGT) officer plans tax-withholding share sale
Rhea-AI Filing Summary
Fulgent Genetics, Inc. (FLGT) is the issuer for a Rule 144 notice filed for the account of Hanlin Gao, an officer. The notice covers a proposed sale of 939 shares of common stock through Morgan Stanley Smith Barney LLC. These shares relate to equity compensation, including restricted stock/RSUs that vested on February 26, 2024, from which 21,146 shares were acquired.
The filer also reports prior sales in the last three months of 945 shares and 1,688 shares of FLGT common stock. According to the statement, the current proposed sale and recent sales were executed as "sell to cover" transactions to satisfy tax withholding obligations tied to RSU vesting, and are described as not representing discretionary trades by the reporting person.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
sell to cover financial
restricted stock vest financial
FAQ
What does the Form 144 filing for FLGT disclose about Hanlin Gao's planned sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.